Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Expression of THBS1 Leads to a Poor Prognosis in Papillary Thyroid Cancer and Suppresses the Anti-Tumor Immune Microenvironment. | Technol Cancer Res Treat | 2022 | 35315710 | PubTator, text mining | PubMed |
| B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells. | Cell Signal | 2022 | 35306137 | PubTator, text mining | PubMed |
| Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets. | Blood Cancer J | 2022 | 35301276 | PubTator, text mining | PubMed |
| PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2. | NPJ Genom Med | 2022 | 35288589 | PubTator, text mining | PubMed |
| Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. | Hemasphere | 2022 | 35284802 | PubTator, text mining | PubMed |
| Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia. | Front Oncol | 2022 | 35273915 | PubTator, text mining | PubMed |
| The Biology of Ocular Adnexal Marginal Zone Lymphomas. | Cancers (Basel) | 2022 | 35267569 | PubTator, text mining | PubMed |
| Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL). | Ther Adv Hematol | 2022 | 35237395 | PubTator, text mining | PubMed |
| Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case. | Haematologica | 2022 | 35236056 | PubTator, text mining | PubMed |
| The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia. | Blood Adv | 2022 | 35235952 | PubTator, text mining | PubMed |
| Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library. | Antibodies (Basel) | 2022 | 35225871 | PubTator, text mining | PubMed |
| Impact of Low-Burden TP53 Mutations in the Management of CLL. | Front Oncol | 2022 | 35211418 | PubTator, text mining | PubMed |
| Lymphoepithelioma-Like Gastric Carcinoma and Gastric Involvement of Chronic Lymphocytic Leukemia: Two Rare Identities Coexisting in One Patient. | J Med Cases | 2022 | 35211234 | PubTator, text mining | PubMed |
| Deep Sequencing of Immunoglobulin Genes Identifies a Very Low Percentage of Monoclonal B Cells in Primary Cutaneous Marginal Zone Lymphomas with CD30-Positive Hodgkin/Reed-Sternberg-like Cells. | Diagnostics (Basel) | 2022 | 35204381 | PubTator, text mining | PubMed |
| The Mysterious Actor-γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL). | Cells | 2022 | 35203309 | PubTator, text mining | PubMed |
| Therapeutic Updates for Richter Syndrome: Highlights From SOHO 2021. | J Adv Pract Oncol | 2022 | 35186405 | PubTator, text mining | PubMed |
| [Chronic lymphocytic leukemia]. | Rev Med Interne | 2022 | 35184869 | PubTator, text mining | PubMed |
| Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2022 | 35163016 | PubTator, text mining | PubMed |
| The Role of Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions. | Cancers (Basel) | 2022 | 35159041 | PubTator, text mining | PubMed |
| Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2022 | 35158929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=34